Coverage
-
December 13, 2023
The U.S. Supreme Court said Wednesday that it would review a dispute over the abortion medication mifepristone, setting up a high court battle over a lower court judge's extraordinary decision to block the U.S. Food and Drug Administration's decades-old approval of the drug.
5 other articles on this case.
View all »